![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phoqus | LSE:PQS | London | Ordinary Share | GB00B0M4CD64 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6198M Phoqus Pharmaceuticals PLC 25 January 2008 Phoqus Pharmaceuticals plc Directors' share dealings West Malling, UK, 25 January 2008: Phoqus Pharmaceuticals plc (AIM: PQS) ("Phoqus" or the "Company"), the drug development company, announces that on 23 January 2008, Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred 106,706 ordinary shares ("Shares") in the Company to exercising option-holders in his capacity as nominee shareholder. As previously announced, share options granted by the Company on 3 November 2005 were to be satisfied by the transfer of Shares held by certain institutional shareholders. In order to facilitate the transfer of Shares to option-holders, some of the institutional shareholders transferred Shares to Dr Peter Johnson, Chief Financial Officer, to hold the Shares as their nominee pending exercise of the share options by the option-holders, after which he would transfer the relevant Shares to the exercising option-holders. Following the above transfer of 106,706 Shares to the exercising option-holders on 23 January 2008, 2,537 Shares are now held by Dr Johnson in his capacity as nominee, representing less than 0.01 per cent of the issued share capital of the Company. Dr Johnson's beneficial ownership of Phoqus Shares remains unchanged at 294,926 ordinary Shares, or 0.64 per cent of the issued share capital of the Company. Enquiries: Phoqus Pharmaceuticals plc Suzanne Smith, Company Secretary Tel: 01732 870227 Nomura Code Securities Limited Phil Walker Tel: 020 7776 1200 This information is provided by RNS The company news service from the London Stock Exchange END RDSEAXFSADFPEFE
1 Year Phoqus Chart |
1 Month Phoqus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions